PulseAugur
EN
LIVE 14:55:14

New benchmark REMEDI evaluates AI unlearning for clinical data

By PulseAugur Editorial · [2 sources] ·

Researchers have introduced REMEDI, a new benchmark designed to evaluate machine unlearning techniques specifically for multi-label clinical disease inference. Existing unlearning methods are often unsuitable for medical applications due to the sensitive nature of patient data and the complexity of clinical datasets. REMEDI utilizes the MIMIC-III database and addresses challenges like label correlations and safety constraints, offering a more realistic evaluation than synthetic datasets. AI

IMPACT Provides a standardized method to test AI model data removal capabilities in sensitive medical contexts.

RANK_REASON The cluster contains a research paper introducing a new benchmark for evaluating machine unlearning techniques.

Read on arXiv cs.LG →

AI-generated summary · Google Gemini · from 2 sources. How we write summaries →

COVERAGE [2]

  1. arXiv cs.AI TIER_1 English(EN) · Anurag Sharma, Sai Teja Chunchu, Prasenjit Mitra, Sandipan Sikdar, Koustav Rudra ·

    REMEDI: A Benchmark for Retention and Unlearning Evaluation in Multi-label Clinical Disease Inference

    arXiv:2606.07141v1 Announce Type: cross Abstract: Language models trained for clinical disease inference are trained on patient data, which may include sensitive and private information, and data owners may request the removal of their data from a trained model due to privacy or …

  2. arXiv cs.LG TIER_1 English(EN) · Koustav Rudra ·

    REMEDI: A Benchmark for Retention and Unlearning Evaluation in Multi-label Clinical Disease Inference

    Language models trained for clinical disease inference are trained on patient data, which may include sensitive and private information, and data owners may request the removal of their data from a trained model due to privacy or copyright concerns. However, exactly unlearning pa…

RELATED ENTITIES

RELATED TOPICS